Brief: GenFleet Therapeutics (Shanghai) Reports Loss Of RMB220.17 Million For Six Months
21/08/2026 09:44
BRIEF-GenFleet Therapeutics (Shanghai) Reports Loss Of RMB220.17 Million For Six Months Aug 21 (Reuters) - GenFleet Therapeutics (Shanghai) Inc 2595.HK:
REPORTS REVENUE OF RMB42.47 MILLION FOR SIX MONTHS ENDED JUNE 30, 2026
REPORTS LOSS OF RMB220.17 MILLION FOR SIX MONTHS ENDED JUNE 30, 2026
Further company coverage: 2595.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GenFleet Therapeutics (Shanghai)
See all newsHK-listed GenFleet jumps on positive progress of cancer drug
GenFleet hits over 3-week high as cancer drug makes progress on BTD list
Brief: GenFleet Therapeutics (Shanghai) Says GFH375 Combined With Cetuximab Placed On Proposed BTD List
HK-listed GenFleet rises most in a month on repurchasing shares
Brief: GenFleet Therapeutics (Shanghai) Reports Loss Of RMB220.17 Million For Six Months